No Data
No Data
KE Holdings' (NYSE:BEKE) Soft Earnings Are Actually Better Than They Appear
KE Holdings-W (02423.HK) spent 3 million USD to repurchase 0.432 million shares on April 29.
On April 29, Gelonghui reported that KE Holdings-W (02423.HK) announced it would spend 3 million USD to repurchase 0.432 million shares on April 29, 2025.
KE Holdings-W (02423.HK) plans to hold a Board of Directors meeting on May 15 to approve the first quarter performance.
On April 30, Gelonghui announced that KE Holdings (02423.HK) will hold a Board of Directors meeting on Thursday, May 15, 2025, to consider and approve the group's unaudited financial performance for the three months ending March 31, 2025, and its release.
U.S. stocks closed: the S&P 500 Index has risen for six consecutive days as investors anticipate Trump to adjust the tariff policy.
① Amazon was forced to terminate the plan to display the impact of tariffs on commodity pages; ② China Concept Stocks fluctuated, and the Nasdaq China Golden Dragon Index fell by 0.3%; ③ Meta released an independent AI application aiming to create a personalized Asia Vets assistant; ④ Starbucks reported a Q2 revenue of 8.8 billion dollars, below market expectations.
KE Holdings-W (02423.HK) spent 2.38 million USD to repurchase 0.339 million shares on April 28.
Gelonghui reported on April 29 that KE Holdings (02423.HK) announced that on April 28, 2025, it spent 2.38 million USD to repurchase 0.339 million shares.
U.S. stocks closed mixed: the three major Indexes showed different trends as investors focused on Technology stock Earnings Reports.
① Most China Concept Stocks rose, with the Nasdaq China Golden Dragon Index up 0.68%; ② IBM announced a 150 billion dollar investment plan; ③ Sony Group is reportedly considering splitting its Semiconductors business; ④ NXP Semiconductors Q1 revenue was 2.84 billion dollars, higher than market expectations.
Cui Nyonya Kueh :
Cui Nyonya Kueh : Today no time for the broke mind stock Nio. Go Other place earn money first.
105232125 : oh dear!
Eugh : W Soleno Therapeutics . 7% up during day trading